0002074593-26-000003.txt : 20260706 0002074593-26-000003.hdr.sgml : 20260706 20260706170245 ACCESSION NUMBER: 0002074593-26-000003 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260706 DATE AS OF CHANGE: 20260706 EFFECTIVENESS DATE: 20260706 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PridCor Therapeutics, LLC CENTRAL INDEX KEY: 0002074593 ORGANIZATION NAME: EIN: 334415956 STATE OF INCORPORATION: AL FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-583403 FILM NUMBER: 261156766 BUSINESS ADDRESS: STREET 1: 1837 COMMONS NORTH DRIVE CITY: TUSCALOOSA STATE: AL ZIP: 35406 BUSINESS PHONE: 2053660696 MAIL ADDRESS: STREET 1: 1837 COMMONS NORTH DRIVE CITY: TUSCALOOSA STATE: AL ZIP: 35406 D/A 1 primary_doc.xml X0708 D/A LIVE 0002074593 PridCor Therapeutics, LLC 1837 COMMONS NORTH DRIVE TUSCALOOSA AL ALABAMA 35406 2053660696 ALABAMA None None Limited Liability Company true 2025 William L Pridgen 1837 Commons North Drive Tuscaloosa AL ALABAMA 35406 Executive Officer Promoter Brian Corday 415 Cullingworth Drive Johns Creek GA GEORGIA 30022 Executive Officer Promoter Pharmaceuticals Decline to Disclose 06b true 0002074593-26-000002 true false true false 20000 NA None None None NA NA XX Unknown 12345 All States false 6045000 0 6045000 false 0 0 0 0 false PridCor Therapeutics, LLC William L. Pridgen, MS William L. Pridgen, MD Chief Executive Officer 2026-07-06